Company profile for Pacira BioSciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Pacira BioSciences, Inc. (Nasdaq: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and prop...
Pacira BioSciences, Inc. (Nasdaq: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
5 Sylvan Way Parsippany, NJ 07054
Telephone
Telephone
(973) 254 3560
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/26/3195373/0/en/Pacira-BioSciences-Files-EXPAREL-Patent-Infringement-Lawsuits-Against-The-WhiteOak-Group-and-Qilu-Pharmaceutical.html

GLOBENEWSWIRE
26 Nov 2025

https://www.globenewswire.com/news-release/2025/11/11/3185358/0/en/Pacira-BioSciences-to-Participate-in-Fireside-Chat-at-Two-Upcoming-Healthcare-Conferences.html

GLOBENEWSWIRE
11 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3183058/0/en/Pacira-BioSciences-Reports-Third-Quarter-2025-Financial-Results-Increases-Full-year-Gross-Margin-Guidance.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181414/0/en/Pacira-BioSciences-Concludes-Patient-Enrollment-in-Part-A-of-Phase-2-Study-Evaluating-Safety-and-Efficacy-of-PCRX-201-for-the-Treatment-of-Osteoarthritis-of-the-Knee.html

GLOBENEWSWIRE
05 Nov 2025

https://www.prnewswire.com/news-releases/amacathera-signs-exclusive-global-licensing-agreement-with-pacira-biosciences-for-up-to-us230-million-validating-its-tunable-drug-delivery-platform-302603911.html

PR NEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/10/30/3177305/0/en/Pacira-to-Report-Third-Quarter-2025-Financial-Results-on-Thursday-November-6-2025.html

GLOBENEWSWIRE
30 Oct 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty